Iovance Biotherapeutics (IOVA) Eyes 60% Revenue Growth, Shares Jump 31%

Iovance Biotherapeutics (NASDAQ: IOVA) saw its share price increase by 31.48 percent on Tuesday, finishing at $14.45 per share after raising its full-year revenue growth guidance by as much as 60 percent, driven by strong demand for its cancer treatments.

In an updated report released the same day, the company said it is now expecting full-year revenues of $410 million to $420 million, up from its previous guidance range of $350 million to $370 million. The new guidance implies an increase of 55.9 percent to 60 percent from the $263 million in revenue reported in 2025.

Iovance Biotherapeutics (NASDAQ: IOVA) said the higher target was supported by a record second quarter, alongside sustained demand for its cancer treatments, Amtagvi and Proleukin.

"Increasing patient demand and our current manufacturing schedule provide strong visibility into our third and fourth quarter revenues. In addition, lifileucel (Amtagvi) continues to advance across our registrational programs in new solid tumor indications, while continued manufacturing and operating efficiencies accelerate our progress toward profitability," Interim President and CEO Frederick Vogt said.

Meanwhile, the company is expected to announce its third-quarter earnings results in early November 2026. Yahoo Finance reports.

🤖 Concentrix Stock Falls After Earnings as AI Transition Weighs on Revenue
Shares of Concentrix were falling in the Wednesday premarket after the company reported mixed fiscal third-quarter results, as it navigates a costly shift toward artificial-intelligence-powered customer-service tools. Barron's reports.

🧩 Why Oracle (ORCL) Stock Is Trading Up Today

Shares of enterprise software giant Oracle (NYSE: ORCL) jumped 4.2% in the afternoon session after the company announced the introduction of Oracle Fusion Claw to expand its artificial intelligence applications and launched new compliance tools for financial institutions.

Oracle Fusion Claw is a governed execution runtime for Fusion Agentic Applications. It combines artificial intelligence reasoning with deterministic enterprise computation across 25 specialist-grade applications.

In addition, Oracle Financial Services launched Oracle Nexus Case Flow and Oracle Nexus Reach. The tools provide agentic artificial intelligence capabilities designed to assist financial institutions with anti-crime investigations and compliance workflows.

After the initial increase, the shares eased to $138.23, up 4% from the previous close. Yahoo Finance reports.

🧾 Why FingerMotion Shares Are Trading Higher by Around 18%

Shares of FingerMotion Inc. (NASDAQ: FNGR) rose sharply in pre-market trading after the company announced that it had entered into a definitive Share Purchase Agreement to acquire 100% of Newbit Technology Inc.

Under the agreement, FingerMotion will purchase 100% of Newbit’s outstanding shares for US$2.3 million in cash on a cash-free, debt-free basis.

FingerMotion shares jumped 18.1% to $0.16 in pre-market trading. Benzinga reports.

🧠 MU Stock Split Chatter Divides Traders Online Ahead of Earnings: 'Would It Make Sense' or Get 'Annihilated'?

Micron Technology Inc. (NASDAQ: MU) shares are trading above $1,000 ahead of its fiscal fourth-quarter earnings report, due after the bell on Wednesday.

A growing chorus of retail traders on social media is betting that the chipmaker will finally announce a stock split as AI and high-bandwidth memory demand push the stock into rarefied territory. Benzinga reports.

🧭 Dow, S&P 500, Nasdaq Futures Little Changed Ahead of PCE Inflation Data

U.S. stock futures were little changed on Wednesday as Treasury yields reached fresh multidecade highs and investors awaited the latest inflation data.

Futures on the Dow Jones Industrial Average rose 0.4%, while S&P 500 futures added 0.2%. Nasdaq-100 futures were also up 0.2% after stocks finished slightly lower the previous session.

Markets remain focused on rising bond yields, volatile oil prices, and inflation concerns as the war in Iran enters its seventh month. Crude oil futures stabilized in the mid-$90-per-barrel range.

Traders also pared back expectations for a Federal Reserve rate hike in October after New York Fed President John Williams said there was "no need for urgency" to raise rates.

Attention now turns to the Personal Consumption Expenditures (PCE) index, the Fed's preferred inflation gauge. Economists expect core PCE, excluding food and energy, to remain unchanged at 3.3% year over year.

Micron will report earnings after the bell, offering investors further insight into the memory and AI markets, while Conagra Brands reports before the bell. Yahoo Finance reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) LGHL: Lion Group Holding Ltd.
Total gain: +82.48%

2) BIYA: Baiya International Group Inc.
Total gain: +17.07%

3) ETRA: Electra Therapeutics, Inc.
Total gain: +16.74%

4) GITS: Global Interactive Technologies, Inc.
Total gain: +12.01%

5) XBP: XBP Global Holdings, Inc.
Total gain: +11.04%

The closing price of the top three market percent gainers trading near or above $2 on Sep 29.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) SDEV: Stablecoin Development Corporation
Total gain: +108.28%

The stock appeared to be moving on no notable news.

2) BKYI: BIO-key International, Inc.
Total gain: +85.71%

The company announced a strategic partnership with Al Majlis Group, the Dubai-based public affairs and advisory group founded by H.E. Dherar Belhoul Al Falasi. GlobeNewswire reports.

3) DXST: Decent Holding Inc.
Total gain: +55.90%

The company announced that its SunCare senior care business has launched an RMB 500-per-month AI-powered in-home senior care service, supported by a strategic collaboration with Ruilan International and leveraging SunCare’s existing base of approximately 200,000 estimated paid members. GlobeNewswire reports.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

MU

Micron Technology

Q4 2026

After Market Close

Estimate: 31.500

Actual: N/A

FDS

FactSet Research Systems

Q4 2026

Before Market Open

Estimate: 4.340

Actual: N/A

CALM

Cal-Maine Foods

Q1 2027

Before Market Open

Estimate: -0.590

Actual: N/A

Time (ET) / Report / Period

• 8:15 AM / ADP National Employment Report / Sep.
• 8:30 AM / Advance U.S. Trade Balance in Goods / Aug.
• 9:45 AM / Chicago Business Barometer - ISM-Chicago Business Survey - Chicago PMI / Sep.

“Risk control isn’t an action so much as it is a mindset.”

– Howard Marks

Sourced in: It’s All a Big Mistake, Oaktree Capital Management.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.